Concepedia

Ying Sun

YS

10

Publications

569

Citations

10

H-Index

2014

Active since

Affiliations

Ambrx (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Torrey Pines Institute For Molecular Studies

Scripps Research Institute

Ying Sun is an author at Ambrx (United States) specializing in medicine, immunotherapy, and tumor biology.

Top concepts

Publications per year

2014–2024

10

Publications

10

A general approach to site-specific antibody drug conjugates

Feng Tian, Yingchun Lu, Anthony Manibusan et al. · Proceedings of the National Academy of Sciences · 2014 · 309 citations · Full text

, , +15

Novel Phosphate Modified Cathepsin B Linkers: Improving Aqueous Solubility and Enhancing Payload Scope of ADCs

Jeffrey C. Kern, Deborah Dooney, Rena Zhang et al. · Bioconjugate Chemistry · 2016 · 89 citations

Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune Cells

Philip E. Brandish, Anthony Palmieri, S. V. Antonenko et al. · Bioconjugate Chemistry · 2018 · 57 citations

Soluble FGL2, a novel effector molecule of activated hepatic stellate cells, regulates T-cell function in cirrhotic patients with hepatocellular carcinoma

Ying Sun, Dong Xi, Wen Ding et al. · Hepatology International · 2014 · 32 citations · Full text

Discovery of orally active chalcones as histone lysine specific demethylase 1 inhibitors for the treatment of leukaemia

Yang Li, Ying Sun, Yang Zhou et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2020 · 18 citations · Full text

Rows per page

1–5 of 10